About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Evaluation of Extended Wear Technology | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04882800

Evaluation of Extended Wear Technology

Evaluating the efficacy and effectiveness of an advancement in the fitting characteristics of extended wear technology with the commercially available device as a comparator.

Lead sponsor: Sonova AG•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Sonova AG

A interventional study in which participants will be fit with the commercially available device in one ear and the experimental device in the opposite ear. After two weeks, the devices will be switched so that the participant has worn each device in each ear for a total of 2 weeks. Participants will be blinded as to which device they are wearing in each ear. Comfort and sound quality will be assessed for each device prior to removing from ears.

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Mild, Moderate and Moderate Severe Hearing loss
•Previous extended wear technology users who rejected or cancelled trials due to discomfort, feedback, migration, or poor sound quality due to fit issues

Exclusion Criteria

•Participants who can only wear a size XXS (extra-extra small) extended wear device
•asymmetrical hearing loss
•other diagnosis that may cause hearing fluctuation
•inability to tolerate physical fit of Lyric devices
•inability to be seen for four lab visits

Related studies

Hidden Hearing Loss in Older Adults

NCT07646119 · Hidden Hearing Loss

Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy

NCT06960616 · Deafness, Cochlear Hearing Loss

Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis

NCT06354010 · Sensorineural Hearing Loss, Bilateral

Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia

NCT04240561 · Hearing Loss, Sensorineural, Dementia of Alzheimer Type, and more

Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device

NCT05365646 · Hearing Loss, Dizziness, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 14, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment15

Start dateApr 2021

Last updatedDec 14, 2022

Condition

Locations shown

Main Line Audiology Consultants

Narberth, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 14, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions